Posted by Clinical Lab Products | Jul 19, 2010 | Cancer, Dementias & Alzheimer’s |
Radient Pharmaceuticals Corp (RPC) announced that it has entered into a letter of intent (LOI) to acquire Provista Diagnostics Inc (PDI), a Nevada corporation offering laboratory testing services that meet the Clinical Laboratory Improvement Act (CLIA) guidelines.
Read MorePosted by Clinical Lab Products | Jul 13, 2010 | Cancer, Miscellaneous |
Clarient Inc announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published.
Read MorePosted by Clinical Lab Products | Jul 9, 2010 | Miscellaneous |
Georgia-Battelle Principal Research Scientist Roy Johnson was part of a team that was awarded the Association of Public Health Laboratories (APHL) Presidential Award for contributions during the influenza H1N1 pandemic response.
Read MorePosted by Clinical Lab Products | Jul 8, 2010 | Miscellaneous |
Health Diagnostic Laboratory Adds CYP2C19 Genetic Testing Health Diagnostic Laboratory Inc announced its new capability to run the CYP2C19 genetic test. HDL Inc, headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its
Read MorePosted by Clinical Lab Products | Jul 7, 2010 | Dementias & Alzheimer’s, Miscellaneous |
Gold Standard Diagnostics Inc (GSD) announced the execution of an agreement with Axis-Shield to distribute their proprietary assays in the US Market.
Read More